2021 Refresher - Pediatrics

This course reviews the treatment guidelines for children with the most common benign and malignant tumors of childhood, with a focus on radiotherapy. Indications for radiotherapy are discussed, in addition to radiotherapy planning guidelines. Clinical outcomes including disease control and toxicity are examined.

Target Audience

The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.

Learning Objectives

    Upon completion of this live activity, attendees should be able to: 

    • Formulate treatment recommendations for common pediatric tumors.
    • Develop radiation treatment plans using appropriate dose, volume, and planning parameters.
    • Recognize the potential acute and late toxicity associated with radiotherapy in the pediatric population.
    Course summary
    Available credit: 
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Course opens: 
    03/19/2021
    Course expires: 
    04/20/2021
    Cost:
    $0.00
    Rating: 
    0

    Julie Bradley, MD is employed by UF Health Proton Therapy Institute and has financial interest from Ion Beam Application.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

    All relevant relationships have been mitigated.

     

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    Policies: 
        • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
        • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
        • ASTRO staff cannot make modifications to your submitted materials.
     

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.